Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...

The biotechnology and drug manufacturing market continues to give investors a hit-and-miss. Bears are betting heavily against Hims and Hers (HIMS), holding a short interest of 28.31%. On May 21, Hims ...

Merck has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.8%. The stock now trades ...

Hims launched generic Semaglutide in Canada, opening a lower-cost alternative to Novo Nordisk’s Ozempic and Wegovy. ・Health Canada recently approved the first generic semaglutide products in the G7.

Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.

Annual Meeting will be held in Chicago from May 29 to June 2, local time. Two registrational studies of the trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate ...

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubmit three biologics ...

A new experiment is seeking to validate whether living cancer samples can be prepared, operated, monitored, and recovered ...

Go behind the scenes of the Cancer Calculus investigation, and hear insights about Merck's cancer drug Keytruda from ICIJ's ...

Telemedicine can absolutely be an effective way to deliver TRT when performed responsibly, agrees Dr. Miller. “In many ways, ...

Maryland caps Ozempic prices for state and local government health plans, aiming to save $5.8 million annually and improve drug affordability.

Find Product Development Latest News, Videos & Pictures on Product Development and see latest updates, news, information from NDTV.COM. Explore more on Product Development.